Literature DB >> 17573752

Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer.

P G Doornebosch1, R A E M Tollenaar, M P Gosselink, L P Stassen, C M Dijkhuis, W R Schouten, C J van de Velde, E J R de Graaf.   

Abstract

OBJECTIVE: Total mesorectal excision (TME) is the gold standard in rectal cancer, if curation is intended. Transanal endoscopic microsurgery (TEM) is a much safer technique and seems to have comparable survival in early rectal cancer. The impact of both procedures on quality of life has never been compared. In this study we compared quality of life after TEM and TME.
METHOD: Fifty-four patients underwent TEM for a T1 carcinoma. Only patients without known locoregional or distant recurrences were included, resulting in 36 eligible patients in whom quality of life after TEM was studied. The questionnaires used included the EuroQol EQ-5D, EQ-VAS, EORTC QLQ-C30 and EORTC QLQ-CR38. The results were compared with a sex-and age-matched sample of T+N0 rectal cancer patients who had undergone sphincter saving surgery by TME and a sex- and age matched community-based sample of healthy persons.
RESULTS: Thirty-one patients after TEM returned completed questionnaires (overall response rate 86%). Quality of life was compared with 31 TME patients and 31 healthy controls. From the patients' and social perspective quality of life did not differ between the three groups. Compared with TEM, significant defecation problems were seen after TME (P < 0.05). A trend towards better sexual functioning after TEM, compared with TME, was seen, especially in male patients, although it did not reach statistical significance.
CONCLUSION: Transanal endoscopic microsurgery and TME do not seem to differ in quality of life postoperatively, but defecation disorders are more frequently encountered after TME. This difference could play a role in the choice of surgical therapy in (early) rectal cancer. Further prospective studies are needed to confirm our conclusions.

Entities:  

Mesh:

Year:  2007        PMID: 17573752     DOI: 10.1111/j.1463-1318.2006.01186.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  31 in total

1.  Robotic TransAnal Minimally Invasive Surgery in a cadaveric model.

Authors:  S B Atallah; M R Albert; T H deBeche-Adams; S W Larach
Journal:  Tech Coloproctol       Date:  2011-09-28       Impact factor: 3.781

2.  Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms.

Authors:  G Rizzo; D P Pafundi; F Sionne; L D'Agostino; G Pietricola; M A Gambacorta; V Valentini; C Coco
Journal:  Tech Coloproctol       Date:  2021-01-18       Impact factor: 3.781

3.  Quality of life and fecal incontinence after transanal endoscopic microsurgery for benign and malignant rectal lesions.

Authors:  Elsa B Valsdottir; Shadi S Yarandi; John H Marks; Gerald J Marks
Journal:  Surg Endosc       Date:  2013-09-12       Impact factor: 4.584

4.  Transanal minimally invasive surgery: a giant leap forward.

Authors:  Sam Atallah; Matthew Albert; Sergio Larach
Journal:  Surg Endosc       Date:  2010-02-21       Impact factor: 4.584

5.  Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences.

Authors:  Ralph Crott; Andrew Briggs
Journal:  Eur J Health Econ       Date:  2010-05-16

6.  Transanal Endoscopic Microsurgery with or without Completion Total Mesorectal Excision for T2 and T3 Rectal Carcinoma.

Authors:  Jeroen W A Leijtens; Thomas W A Koedam; Wernard A A Borstlap; Monique Maas; Pascal G Doornebosch; Tom M Karsten; Eric J Derksen; Laurents P S Stassen; Camiel Rosman; Eelco J R de Graaf; André J A Bremers; Jeroen Heemskerk; Geerard L Beets; Jurriaan B Tuynman; Kevin L J Rademakers
Journal:  Dig Surg       Date:  2018-05-23       Impact factor: 2.588

Review 7.  Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.

Authors:  Marco E Allaix; Alberto Arezzo; Mario Morino
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

8.  Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.

Authors:  Giancarlo D'Ambrosio; Alessandro M Paganini; Andrea Balla; Silvia Quaresima; Pietro Ursi; Paolo Bruzzone; Andrea Picchetto; Fabrizio I Mattei; Emanuele Lezoche
Journal:  Surg Endosc       Date:  2015-06-05       Impact factor: 4.584

9.  Transanal Endoscopic Microsurgery (TEMS) for Rectal Cancer: Patient Decision-making, Postoperative Experience and Quality of Life.

Authors:  Alexandra Koreli; George Briassoulis; Michail Sideris; Anastas Philalithis; Savvas Papagrigoriadis
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

10.  Transanal minimally invasive surgery for rectal polyps and selected malignant tumors: caution concerning intermediate-term functional results.

Authors:  S H E M Clermonts; Y T van Loon; A H W Schiphorst; D K Wasowicz; D D E Zimmerman
Journal:  Int J Colorectal Dis       Date:  2017-09-13       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.